UBS cuts Xponential Fitness price target as guidance cut signals weaker growth

What happened

Xponential Fitness (NYSE:XPOF) lowered its fiscal 2026 guidance to revenue of $250–260 million and EBITDA of $91–97 million, citing weaker sales and slower studio expansion. UBS responded by cutting its price target to $4.50 from $7, reflecting concerns about franchisee health and growth quality. The DeepValue master report already flagged fragile fundamentals, including negative equity, weak interest coverage, and recurring net losses, making this guidance cut a confirmation of existing risks. While the company retains a scaled, capital-light franchise model, the deteriorating revenue trajectory and cautious outlook reduce confidence in near-term recovery. Investors should view this news as validating the prior WAIT stance and increasing the likelihood of further downside if trends do not stabilize.

Implication

Existing holders should closely monitor cash flow generation, leverage reduction, and any stabilization in same-store sales or net studio openings, as persistent weakness could warrant a downgrade to SELL. The guidance cut and analyst price target reduction signal that the market is pricing in slower growth and potential impairments, aligning with the deep report's concerns about franchisee economics. Legal and regulatory overhangs remain significant, and any adverse resolution could further pressure the stock. Conversely, a successful turnaround under new leadership, combined with de-risking of the balance sheet and legal issues, could eventually support a more constructive view, but that remains unproven. Until clear evidence of operational improvement emerges, we recommend avoiding new positions and focusing on risk management for existing ones.

Thesis delta

The prior WAIT thesis was based on a fragile balance sheet, weak interest coverage, and an unattractive risk/reward despite a large studio network. The new guidance cut and lower price target confirm deteriorating fundamentals and slower expansion, validating the bearish concerns outlined in the deep report. Consequently, the thesis shifts from a neutral WAIT to a more defensive WAIT, with heightened probability of a downgrade to SELL if weak sales and franchisee distress persist. No change in the overall negative bias, but downside risks are now more clearly confirmed by management guidance.